Mark Kohlenberg explains the importance of sustainability and reinvention.

1 min read

Opinions expressed by Entrepreneur contributors are their own.

Mark Kohlenberg, CEO and founder of Moral Code Footwear, shares how he found a career in the footwear industry by chance. He also talks about how the business has helped him to unlock his tenacity and find the passion to confront the constant change that occurs in the fashion world.

Kohlenberg and The Playbook host David Meltzer discuss a variety of topics, including how sustainability trends impact the market today and in the future, the necessity of reinvention for fashion entrepreneurs and the biggest changes they’ve seen in today’s workforce. The pair also converse about their drive to be compassionate capitalists who make a positive impact on those around them.

Related: Can Cold Exposure Help Improve Your Long-Term Health?

Source link

GM announced the second major expansion of its full-size pickup production capacity this year: with a $150 million investment at Flint Assembly to increase production of the all-new Chevrolet Silverado and GMC Sierra heavy-duty pickups.

JEFF KOWALSKY | AFP | Getty Images

General Motors said Monday that it is suspending its quarterly dividend and stock buybacks to preserve cash during the coronavirus pandemic.

The automaker said it also extended a $3.6 billion, three-year revolving credit facility to April 2022 to help bolster its liquidity. GM said it’s “taken other significant austerity measures to preserve near-term available cash.”

GM’s U.S. plants have been shuttered since mid-March due to Covid-19. The automaker along with Ford Motor and Fiat Chrysler are in discussions with the United Auto Workers union to reopen the plants, however union leaders last week said that they oppose an early-May restart, which several automakers have announced.

GM and Ford are among the only major automakers that have yet to announce a time frame to restart production. Fiat Chrysler earlier this month announced plans to restart production on May 4.

This is breaking news. Please check back for updates.

Source link

Bayer AG raised the specter of “considerable liquidity challenges” as it engages in high-stakes negotiations over Roundup litigation in the U.S. and grapples with the pandemic.

The number of plaintiffs claiming that the weedkiller caused their cancers rose to 52,500 from 48,600 in February, Bayer said in its first-quarter earnings statement. It’s still too early to know how Covid-19 will impact this year’s results, but the outbreak has already slowed talks with plaintiff attorneys. Bayer said it’s pushing for a “financially reasonable” settlement that also resolves the potential for future claims.

“Against the background of a looming recession and looking at, in part, considerable liquidity challenges, this applies now more than ever,” the company said.

The Roundup talks remain the biggest question hanging over Chief Executive Officer Werner Baumann, who faces a confidence vote at Tuesday’s annual meeting. He lost the vote last year after Bayer suffered multiple U.S. trial defeats, cratering the company’s stock price and raising questions about the wisdom of the $63 billion takeover of Monsanto Co.

Crop Science Demand

Bayer rose as much as 3.8% Monday in Frankfurt, paring this year’s losses to 15%. The Euro Stoxx 50 Index rose 1.9% — in step with equities …

Billionaire Bill Gates is funding production of the seven most promising ideas for a vaccine as he refocuses his philanthropic work on the deadly coronavirus.

“If everything went perfectly, we’d be in scale manufacturing within a year,” Gates said on CNN’s “Fareed Zakaria GPS.” “It could be as long as two years.”

The world’s second-richest man said vaccine production will probably not start in September, as some have said.

Dr. Fauci and I have been fairly consistent to say 18 months to create expectations that are not too high,” Gates said, referring to Anthony Fauci, director of the National Institute of Allergy and Infectious Diseases and a member of the White House coronavirus task force.

The availability of testing for the coronavirus has been a sore spot in the U.S. for months. President Donald Trump tweeted on Saturday that the U.S. “just passed 5 million Tests, far more than any other country.”

Just looking at raw numbers misses the true picture, Gates said.

“This focus on the number of tests understates the cacophony and the mistakes we’ve made in the testing system,” Gates said. “The wrong people are being tested, and any time you don’t get …